Review
FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option
Study on active menopause symptoms and treatments.
Citation
Elendu C, Okahia TW, Blewusi GS, Meduoye OOM, Ogelle EC, Egbo AR, Nwankwo VC, Amaefule KC, Emechebe SL, Mohamed AA, Ogedengbe OS, Aggreh OP, Obi DI, Orji VI, Bakare SO, Adediran FD, Adetoye F, Akande BA, Ogunsola OC, Olanlege AM. FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option.. Annals of medicine and surgery (2012). 2025;87(9):5373-5377. doi:10.1097/MS9.0000000000003670
View Source